1.Investigation on the Serum NGAL Reference Range of Healthy Populations in Xi'an
Ruijie SHI ; Futang YAN ; Wenkang LIU ; Hua ZHANG ; Jun YUAN ; Peng MI ; Shuling HU ; Xiao ZHENG
Journal of Modern Laboratory Medicine 2017;32(4):130-132
Objective To establish serum NGAL reference range of healthy populations in Xi'an Area.Methods 2 665 cases (aged 6 to 95 years old,male 1 370,female 1 295) of health-check people were collected from March 2014 to October 2016 in Medical Examination Center of Shaanxi Provincial People's Hospital,and 682 cases (aged 0 to 6 years old,male 356,female 326) were collected from preschool children of prevention.Serum NGAL concentration of them were analysed by immunoturbidimetry method with the Automatic Biochemical Analysis Assembly Line of Beckman-AU5800,and the detection data for statistical analysis.Then established the reference range of serum NGAL population of different age and different sex in Xi'an.Results The serum NGAL levels in healthy subjects showed a skewed distribution,which were preschool children under 6 years of age 37.66±23.12 ng/ml,6~15 years 39.25±25.34 ng/ml,16~49 years 46.68±27.06 ng/ml,and 50~ 69 years 57.82±29.13 ng/ml.Compared the first two with the latter,there was a significant difference (t=0.589,P< 0.05).The serum NGAL levels of over 70 years were 61.87 ± 32.64 ng/ml,and there was a significant difference between the ages of 15 and 49 and over 70 years (t=8.529,P<0.01).At the same time,the serum NGAL was closely correlated with age (r=0.298,P<0.01).But there was no significant difference in serum NGAL level between male and female (t=0.263~0.542,all P>0.05).87ng/ml was the upper limit of the reference value for the age of 50 years.Conclusion The level of serum NGAL was related to age and increased with age,but not with gender.
3.Study on technology of extracting geniposidic acid from Eucommia ulmiodes and its application.
Mi-jun PENG ; Chun-shan ZHOU ; Qi-fu LEI ; Long-sheng CHEN
China Journal of Chinese Materia Medica 2004;29(3):229-277
OBJECTIVETo study the optimum technology of extracting bioactive component named geniposidic acid in Eucommia Ulmiodes by orthogonal test.
METHODAn orthogonal test table L16(4(5)) was used with the factors of extracting time, temperature, times, ethanol consistency and the ratio of solid to liquid. The content of geniposideic acid was determined by RP-HPLC.
RESULTThe optimum technology was: temperature 50 degrees C, time 1 h, once, consistency 80%, and the ratio of solid and liquid 1:12. Under the condition, the best material of Eucommia Ulmiodes for extracting geniposidic acid was chosen.
CONCLUSIONThe technology can provide some theoretic advice for industry.
Chromatography, High Pressure Liquid ; Ethanol ; Eucommiaceae ; chemistry ; Glucosides ; analysis ; isolation & purification ; Iridoid Glucosides ; Iridoids ; analysis ; isolation & purification ; Plant Bark ; chemistry ; Plants, Medicinal ; chemistry ; Technology, Pharmaceutical ; methods ; Temperature ; Time
4.Artesunate suppresses human endometrial carcinoma RL95-2 cell proliferation by inducing cell apoptosis.
Jun-sheng ZHENG ; Ming-hua WANG ; Min HUANG ; Yun-peng LUO ; Can MI
Journal of Southern Medical University 2008;28(12):2221-2223
OBJECTIVETo investigate the inhibitory effect of artesunate on human endometrial carcinoma RL95-2 cell line proliferation in vitro and the possible mechanisms.
METHODSThe inhibitory effect of artesunate on the cell proliferation was assessed with MTT assay. Transmission electron miscrosopy was used to observe the morphological change of the cells after the treatment. Flow cytometry was performed to examine the changes in the cell cycle, reactive oxygen species (ROS) levels (with DCFH-DA labeling) and mitochondrial membrane potential (rhodamine123 staining), and caspase-3 activity was detected by immunohistochemistry.
RESULTSArtesunate inhibited the proliferation of RL95-2 cells with an IC(50) of 26.29 microg/ml. Transmission electron microscopy revealed early apoptotic changes of the cells with obvious chromatin fragmentation. The cell cycle arrest at G(0)/G(1) phase was observed by flow cytometry, and immunohistochemistry demonstrated caspase-3 positivity in cytoplasm. ROS generation in the cells increased obviously after treatment with artesunate for 72 h, which also resulted in lowered mitochondrial membrane potential.
CONCLUSIONArtesunate suppressed the proliferation of RL95-2 cells in vitro possibly by inducing cell apoptosis.
Antineoplastic Agents, Phytogenic ; pharmacology ; Apoptosis ; drug effects ; Artemisinins ; pharmacology ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Endometrial Neoplasms ; pathology ; Female ; Humans
5.Treatment of Proteinuria in Chronic Glomerular Disease Patients with Pi-Shen Deficiency Complicated Damp-Heat Syndrome by Yishen Qingre Huashi Recipe: a Clinical Study.
Qin DAI ; Pei-qing ZHANG ; Xiao-qin WANG ; Li-fang NIE ; Xiao-jun FU ; Wen PENG ; Yi WANG ; Jun LI ; Yue-ping BI ; Xiu-hua MI ; Min YUAN ; Li-qun HE
Chinese Journal of Integrated Traditional and Western Medicine 2015;35(9):1039-1043
OBJECTIVETo observe the therapeutic effect of Yishen Qingre Huashi Recipe (YQHR) in treating proteinuria of chronic glomerular disease patients with Pi-Shen deficiency complicated damp-heat syndrome (PSDCDHS).
METHODSTotally 121 stage 1 -2 primary chronic glomerular disease patients with PSDCDHS were randomly assigned to the treated group (85 cases) and the control group (36 cases) according to 2:1. All patients received conventional and symptomatic treatment. Patients in the treated group took YQHR additionally, while those in the control group took Losartan Potassium Tablet (50 mg each time, once per day) additionally. The therapeutic course for all was 6 months. Changes of 24 h urine protein, blood urea nitrogen (BUN), serum creatinine(SCr), and estimated glomerular filtration rate (eGFR) were observed at different time points. And the difference in therapeutic effects were compared between the two groups.
RESULTSCompared with the control group after 6 months of treatment, 24 h urine protein obviously decreased in the treated group (P <0. 05). There was no statistical difference in SCr, BUN, or eGFR between the two groups after 6 months of treatment (P >0. 05). The total effective rate after 2, 4, and 6 months of treatment in the treated group was 77. 6% (66/85 cases), 82. 4% (70/85 cases), and 89. 4% (76/85 cases), respectively. They were 47. 2% (17/36 cases), 55. 6% (20/36 cases), and 61. 1% (22/36 cases) in the control group, respectively. Compared with before treatment in the treated group, the total effective effect after 6 months of treatment was higher than that after 2 months of treatment (χ2=4. 28, P <0. 01). Compared with the control group at the same time points, the total effective rate in the treated group after 2, 4, and 6 months of treatment was higher (χ2=10. 87, 9. 53, 13.16, P <0. 01).
CONCLUSIONYQHR could significantly lower proteinuria in chronic glomerular disease patients with PSDCDHS, improve the clinical effect, thereby providing clinical evidence for treating chronic glomerular disease proteinuria from resolving dampness and clearing heat.
Blood Urea Nitrogen ; Drugs, Chinese Herbal ; therapeutic use ; Hot Temperature ; Humans ; Kidney Diseases ; complications ; therapy ; Kidney Glomerulus ; pathology ; Losartan ; Medicine, Chinese Traditional ; Phytotherapy ; Proteinuria ; etiology ; therapy ; Syndrome ; Tablets
6.Effects of different dietary fatty acid on expression of nuclear receptor genes in breast cancer of rats.
Na WEI ; Man-tian MI ; Bin WANG ; Jun-dong ZHU ; Da-peng ZHU ; Jia-lin YUAN
Chinese Journal of Preventive Medicine 2007;41(4):271-276
OBJECTIVETo study the effects of different dietary fatty acid on the expression of nuclear receptor genes in the breast cancer of rats.
METHODSFifty-day-old female Sprague-Dawley rats were fed on eight different diets containing following fatty acids: saturated fatty acid (SFA); monounsaturated fatty acid (MUFA); n-6 polyunsaturated fatty acid (PUFA); n-3 PUFA; 1:1 n-6/n-3; 5:1 n-6/n-3; 10:1 n-6/n-3; 1:2:1 S/M/P (n-6/n-3 at 1:1). The rats were given a single intraperitoneal injection of methyl-nitrosourea (MNU) at 50 mg/kg body weight to establish the rat model of mammary carcinogenesis, the ultrastructure changes of mammary gland cells in rats were observed by transmission electron microscope, the cell proliferation activity was detected by BrdU-labeled immunocytochemistry, and the expression of PPARbeta and PPARgamma mRNA were assayed by RT-PCR.
RESULTSThere was no breast cancer occurring in control groups and the MNU-treated n-3 PUFA group, and the ultrastructure and proliferation activity of mammary gland cells in these groups were normal. In contrast, there appeared obvious marker of adenocarcinomas in mammary gland cells of MNU-induced breast cancer, and a high cell proliferation activity was found in tumor growth-enhancing groups (SFA, MUFA, n-6 PUFA, 5:1 n-6/n-3, 10:1 n-6/n-3 and S/M/P, 21% - 22% of BrdU-labeled cells), while a low cell proliferation activity was detected in rats fed with 1:1 n-6/n-3 diet (13% of BrdU-labeled cells, P < 0.05). Moreover, peroxisome proliferator-activated receptors (PPARs), as important nuclear receptor genes of relating lipid metabolism, the expressions of PPARbeta and PPARgamma mRNA were significantly up-regulated in mammary adipose tissues of MNU-induced breast cancer as compared with the control groups, but the expression levels of peroxisome proliferator-activated receptors (PPARs) in rats fed with 1:1 n-6/n-3 group were lowest (P < 0.05).
CONCLUSIONThe different dietary fatty acid compositions should diversely adjust the expression of PPARs gene in rats, which maybe have an important role in affecting incidence of breast cancer.
Animals ; Fatty Acids ; pharmacology ; Fatty Acids, Omega-3 ; pharmacology ; Fatty Acids, Omega-6 ; pharmacology ; Fatty Acids, Unsaturated ; pharmacology ; Female ; Gene Expression ; Gene Expression Regulation, Neoplastic ; Mammary Neoplasms, Experimental ; genetics ; PPAR gamma ; genetics ; RNA, Messenger ; genetics ; Rats ; Rats, Sprague-Dawley
7.Clinical results of multi-artery-graft and single-artery-graft off-pump coronary artery bypass grafting: a propensity score matching follow-up study
xiong Peng ZHU ; qing An CHEN ; Jun LIU ; Zhe WANG ; feng Xiao YE ; Mi ZHOU ; Qiang ZHAO
Journal of Shanghai Jiaotong University(Medical Science) 2017;37(12):1658-1663
Objective·To explore the difference between multi-artery-graft off-pump coronary artery bypass grafting (OPCABG) and single-artery-graft OPCABG on left main coronary artery or multivessel disease with propensity score matching. Methods·A total of 1578 patients with left main coronary artery or multivessel disease underwent isolated OPCABG were selected in Ruijin Hospital from January 2012 to September 2016. The propensity score methodology was used to obtain risk-adjusted outcome. Kaplan-Meier analysis was applied for estimation of freedom from major adverse cardiac and cerebrovascular events (MACCE) and readmission for heart disease. Independent predictor of MACCE were assessed by Cox regression analysis. Results·The average follow-up time was 28 months (7-55 months). There was no statistical difference in short-term clinical endpoints in hospital. In the follow-up results, multi-artery-graft OPCABG patients had statistical improvement in readmission for heart disease (2.7% vs 12.7%, P=0.023), CCS class (1.2±0.4 vs 1.4±0.6, P=0.020) and patency rate of grafts in 1 year after operation (95.8% vs 85.9%, P=0.025), compared with single-artery-graft OPCABG. There was no statistical difference in other endpoints. There was statistical improvement for multi-artery-graft OPCABG patients in freedom from readmission for heart disease (P=0.028). Female was an independent predictor of MACCE (95% CI 0.117-0.906, P=0.032). Conclusion·Multi-artery-graft OPCABG appears to be safe and with good patency of grafts and clinical outcomes in treating left main coronary artery or multivessel disease. The follow up of female patients should be paid more attention.
8.Protective effects of Salvianolic acid on myocardial ischemic injury of rats from the aspect of inhibiting inflammatory reaction
Xiu-Ping QIN ; Meng-Xi XU ; Rong-Rong HAO ; Mi-Xia ZHANG ; Peng-Wei ZHUANG ; Guang-Zhi CUI ; Yan-Jun ZHANG
The Chinese Journal of Clinical Pharmacology 2017;33(9):794-797
Objective To investigate the protective effects of Salvianolic acid on myocardial ischemic injury of rats from the aspect of inhibiting inflammatory reaction.Methods Sixty Sprague Dawley (SD) male rats were randomly divided into four groups (n =15per group):sham operation group,model group,experimental-high (36 mg · kg-1) group,experimental-low (18mg · kg-1) group with intraperitoneal injection dosing.Same amount of distilled water was injected to sham operation group and model group,lasting for 4 days.Myocardial ischemia model was established by coronary artery ligation of left anterior descending (LAD) branch after the last administration.Six hours after the operation,the blood of eye canthus was collected to assay the levels of creatine kinase(CK),MB isoenzyme of creatine kinase (CK-MB) and lactate dehydrogenase (LDH) in serum.The heart was collected 24 h after the operation,stained by hematoxylin eosin (HE)and checked the pathological change of the cardiac muscle tissue,assayed the cardiac troponin (cTnT),tumor necrosis factor α (TNF-α) in serum and myeloperoxidase (MPO) was measured in myocardial tissue homogenate.Results After 6 hours' myocardial ischemia,the serum CK in sham operation group was (529.61 ± 141.93) U · L-1,CK-MB was (708.12 ±385.93) U · L-1,LDH was (330.12 ±158.38) U · L-1 and cTnT was (294.12 ±55.10)pg· mL-1 after 24 hours' myocardial ischemia.The serum CK in model group was (996.42 ± 413.42) U · L-1,CK-MB was (1346.11 ±558.30) U · L-1,LDH was (520.12 ±154.76) U · L-1and cTnT was (513.00 ±69.71)pg · mL-1after 24 hours' myocardial ischemia.The serum CK in experimental-low and experimental-high groups were (499.45 ±159.33),(514.91 ±98.82)U · L-1,CK-MB were (831.42 ±385.11),(592.10 ±206.32)U·L-1,LDH were (462.62 ±229.68),(437.72 ± 175.80)U· L-1,and cTnT were (431.12 ±106.00),(338.80 ± 76.92)pg · mL-1after 24 hours' myocardial ischemia.Compared with the sham operation group,the CK,CK-MB and LDH value in the serum of model group increased significantly (P < 0.05).Compared with the model group,the salvianolic acid significantly both can decrease the CK and CK-MB in serum (P < 0.05).Compared with sham operation group,the cTnT value in the serum of model group increased significantly (P < 0.05).Compared with model group,high dosage of salvianolic acid could significantly decrease the cTnT value (P < 0.05).After 24 hours'myocardial ischemia,the TNF-α in serum of sham operation group was (118.90 ± 17.58) pg · mL-1,the MPO in heart tissue was (32.25 ± 3.75) U · L-1.The TNF-α in serum of model group was (156.00 ± 28.24) pg · mL-1,the MPO in heart tissue was (104.83 ±22.87) U · L-1.The TNF-α in serum of experimental-low and experimental-high groups were (136.05 ± 34.00),(125.06 ± 30.13) pg · mL-1,the MPO in heart tissue were (91.70 ±21.57),(68.00 ± 18.47) U · L-1.Compared with sham operation group,the TNF-α values in the serum and the MPO value in model group increased significantly (P < 0.05).Compared with model group,these values of experimental-high group decreased with significantly (all P < 0.05).Conclusion Salvianolic acid showed the protection of myocardial tissue,which also could significantly reduce the myocardial cell injury and inflammatory cell infiltration of cardiac myocytes,which could be related with the decreased levels of TNF-α and MPO.
9.Clinical trial of tenofovir combined with polyethylene glycol interferon α 2a injection in the treatment of drug resistance patients with chronic hepatitis
Zhi-Peng LIN ; Mi-Long SU ; Zhi-Jun SU ; Jiang-Fu LIU ; Yi-Juan ZHENG
The Chinese Journal of Clinical Pharmacology 2018;34(2):108-110
Objective To evaluate the clinical effect of tenofovir combined with polyethylene glycol interferon α2a injection in the treatment of drug resistance patients with chronic hepatitis.Methods Seventy-six patients with drug-resistant chronic hepatitis were divided into control group and treatment group,38 cases in each group.Control group was treated with tenofovir 300 mg,qd,orally.Treatment group was treated with pegylated interferon α2a injection 180 μg on the basis of control group,1 time per week,subcutaneous injection.All patients were treated for 48 weeks.Clinical effect,serum hepatitis B virus deoxyri bonucleic acid (HBV-DNA),alanine aminotransferase (ALT),aspartate aminotransferase(AST),HBV-DNA negative rate and adverse drug reactions in two group were evaluated.Results After treatment,the total effective rates in treatment group and control group were 86.84% (33 cases/38 cases) and 65.79% (25 cases/ 38 cases),the HBV-DNA overcast rates were 73.68% (28 cases/38 cases) and 50.00% (19 cases/38 cases),with significant difference (P < 0.05).The serum HBV DNA in treatment group and control group were (2.98 ± 0.35) and(4.13 ± 0.43) log10 copies · mL-1,ALT were (38.97 ± 8.44) and (58.51 ± 8.15) U · L-1,AST were (39.13 ±4.21) and (50.62 ±6.45) U · L-1,with significant difference (P <0.05).There were 3 cases of dizziness,5 cases of gastrointestinal reaction in control group,and were 4 cases of abnormal blood system,3 cases of gastrointestinal tract reaction,3 cases of skin abnormalities in treatment group.The incidence of adverse drug reactions in control group and treatment group were 21.05% (8 cases/38 cases) and 26.32% (10 cases/38 cases),with no significant difference (P > 0.05).Conclusion The clinial effect of tenofovir combined with polyethylene glycol interferon α2a injection in the treatment of drug resistance patients with chronic hepatitis is better than tenofovir alone,and can reduce the serum HBV-DNA,ALT,AST.
10.Clinical practice and evaluation of relative fluid resuscitation formula at burn shock stage.
Gao-xing LUO ; Yi-zhi PENG ; Ying ZHUANG ; Li-hui ZHANG ; Mi ZHOU ; Wen-guang CHENG ; Jun WU ; Jia-ping ZHANG ; Zhi-qiang YUAN ; Qi-zhi LUO ; Yue-sheng HUANG
Chinese Journal of Burns 2008;24(4):248-250
OBJECTIVETo evaluate the application of the Third Military Medical University (TMMU) formula for fluid resuscitation on the major burn patients during shock stage.
METHODSSeventy-one thermal injury patients (burn area more than 30% TBSA, without especial illness, hospitalization within 8 hour after burn) admitted from 2005 to 2007 were divided into adult group (n = 46), child group (n = 25). Fluid resuscitation was initiated as per the TMMU formula.
RESULTSAll patients survived the first 48 hours post burn injury and none developed recognized complications associated with fluid resuscitation. The average infused fluid was 16% approximately 38% more than the calculated in both adult and child groups. The average urine output during the first 24 hours post burn injury was 1.1 approximately 1.2 mL x kg(-1) x h(-1) in the two groups, but reached 1.2 mL and 1.7 mL x kg(-1) x h(-1) during the second 24 hours in adult and child groups respectively.
CONCLUSIONTMMU formula for fluid resuscitation is a feasible option for major burn patients. Individual fluid resuscitation, guided by the physiological response, is also important and necessary.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Burns ; therapy ; Child ; Child, Preschool ; Female ; Fluid Therapy ; methods ; Humans ; Infant ; Male ; Middle Aged ; Shock ; therapy ; Young Adult